{"id":7285,"date":"2015-10-28T14:08:06","date_gmt":"2015-10-28T12:08:06","guid":{"rendered":"https:\/\/faus-moliner.com\/?p=7285"},"modified":"2016-03-04T15:11:31","modified_gmt":"2016-03-04T13:11:31","slug":"liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies","status":"publish","type":"post","link":"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/","title":{"rendered":"Liberalisation of discounts offered by pharmaceutical companies to pharmacies"},"content":{"rendered":"<p><strong>Maximum rate eliminated<\/strong><\/p>\n<p>As of 1 January 2016, the maximum discount rate of 10% that distributors and pharmaceutical companies were allowed to offer pharmacies on medicinal products financed by Spain&#8217;s National Healthcare System (SNS) will disappear.<\/p>\n<p>In this respect, it is important to recall that the general rules governing competition fully apply to the sale of medicinal products to pharmacies. The elimination of the maximum limit does not mean that selling at a loss is allowed. According to the Unfair Competition Act, sales below acquisition cost are considered unfair if they are part of a strategy designed to eliminate a competitor or group of competitors from the market.<\/p>\n<p><strong>Types of discounts<\/strong><\/p>\n<p>The law continues establishing that discounts\u00a0may only be offered for early payment or\u00a0purchase volume. Moreover, in order for such\u00a0discounts to be admissible, they must not\u00a0encourage the purchase of a product in\u00a0prejudice of a competitor&#8217;s product. The\u00a0wording of this clause is rather unfortunate,\u00a0because anyone who offers a discount obviously\u00a0does so with the aim of encouraging customers\u00a0to purchase their product. In any case, the most\u00a0reasonable interpretation in our view is that a\u00a0discount may not be offered on the condition\u00a0that the pharmacy purchases all or practically all\u00a0its needs of a product from one company.<\/p>\n<p><strong>Invoices, credit notes and monthly register<\/strong><\/p>\n<p>The obligation to itemise discounts on invoices remains included the law. To our understanding, this does not preclude the possibility of rappel discounts issuing a credit note to be paid after the sale, the amount of which may be calculated according to the purchase volume for a given period.<\/p>\n<p>In addition to the corresponding invoices, discounts affecting medicinal products financed by the NHS must be recorded in a monthly register telematically connected with the Spanish Ministry of Health. The Law does not indicate the purpose of such register.<\/p>\n<p><strong>What about medical devices?<\/strong><\/p>\n<p>Once again, it seems that this category has been overlooked by legislators. At first glance, the Law allows discounts to pharmacies without limiting them to medicinal products, so there is nothing preventing the offering of a discount on government-financed medical devices. However, the Law only refers to financed medicinal products in the provision regulating the monthly register. Therefore, it could be possible to offer unlimited discounts on government-financed medical devices without the obligation to enter them in the telematically connected monthly register. Some may interpret the Law as allowing only discounts on financed medicinal products subject to inclusion in the monthly register, but this would be a forced and highly debatable interpretation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Maximum rate eliminated As of 1 January 2016, the maximum discount rate of 10% that distributors and pharmaceutical companies were allowed to offer pharmacies on medicinal products financed by Spain&#8217;s National Healthcare System (SNS) will disappear. In this respect, it is important to recall that the general rules governing competition fully apply to the sale&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/\" class=\"excerpt-read-more\">Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[72,86,217],"tags":[],"coauthors":[105],"class_list":["post-7285","post","type-post","status-publish","format-standard","hentry","category-capsulas-en","category-pharmaceutical-and-life-sciences-law","category-pharmaceutical-and-life-sciences-law-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Liberalisation of discounts offered by pharmaceutical companies to pharmacies - Faus Moliner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Liberalisation of discounts offered by pharmaceutical companies to pharmacies - Faus Moliner\" \/>\n<meta property=\"og:description\" content=\"Maximum rate eliminated As of 1 January 2016, the maximum discount rate of 10% that distributors and pharmaceutical companies were allowed to offer pharmacies on medicinal products financed by Spain&#8217;s National Healthcare System (SNS) will disappear. In this respect, it is important to recall that the general rules governing competition fully apply to the sale... Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/\" \/>\n<meta property=\"og:site_name\" content=\"Faus Moliner\" \/>\n<meta property=\"article:published_time\" content=\"2015-10-28T12:08:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-03-04T13:11:31+00:00\" \/>\n<meta name=\"author\" content=\"Jordi Faus\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jordi Faus\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/\"},\"author\":{\"name\":\"Jordi Faus\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\"},\"headline\":\"Liberalisation of discounts offered by pharmaceutical companies to pharmacies\",\"datePublished\":\"2015-10-28T12:08:06+00:00\",\"dateModified\":\"2016-03-04T13:11:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/\"},\"wordCount\":433,\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"articleSection\":[\"Capsulas\",\"Pharmaceutical and Life Sciences Law\",\"Pharmaceutical and Life Sciences Law\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/\",\"url\":\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/\",\"name\":\"Liberalisation of discounts offered by pharmaceutical companies to pharmacies - Faus Moliner\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\"},\"datePublished\":\"2015-10-28T12:08:06+00:00\",\"dateModified\":\"2016-03-04T13:11:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/faus-moliner.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Liberalisation of discounts offered by pharmaceutical companies to pharmacies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"name\":\"faus-moliner.com\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/faus-moliner.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\",\"name\":\"Faus Moliner\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"contentUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"width\":400,\"height\":283,\"caption\":\"Faus Moliner\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/2372042\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\",\"name\":\"Jordi Faus\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"caption\":\"Jordi Faus\"},\"description\":\"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.\",\"sameAs\":[\"https:\/\/faus-moliner.com\/\"],\"url\":\"https:\/\/faus-moliner.com\/en\/author\/jordi-faus\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Liberalisation of discounts offered by pharmaceutical companies to pharmacies - Faus Moliner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/","og_locale":"en_US","og_type":"article","og_title":"Liberalisation of discounts offered by pharmaceutical companies to pharmacies - Faus Moliner","og_description":"Maximum rate eliminated As of 1 January 2016, the maximum discount rate of 10% that distributors and pharmaceutical companies were allowed to offer pharmacies on medicinal products financed by Spain&#8217;s National Healthcare System (SNS) will disappear. In this respect, it is important to recall that the general rules governing competition fully apply to the sale... Read More","og_url":"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/","og_site_name":"Faus Moliner","article_published_time":"2015-10-28T12:08:06+00:00","article_modified_time":"2016-03-04T13:11:31+00:00","author":"Jordi Faus","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jordi Faus","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/#article","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/"},"author":{"name":"Jordi Faus","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260"},"headline":"Liberalisation of discounts offered by pharmaceutical companies to pharmacies","datePublished":"2015-10-28T12:08:06+00:00","dateModified":"2016-03-04T13:11:31+00:00","mainEntityOfPage":{"@id":"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/"},"wordCount":433,"publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"articleSection":["Capsulas","Pharmaceutical and Life Sciences Law","Pharmaceutical and Life Sciences Law"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/","url":"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/","name":"Liberalisation of discounts offered by pharmaceutical companies to pharmacies - Faus Moliner","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/#website"},"datePublished":"2015-10-28T12:08:06+00:00","dateModified":"2016-03-04T13:11:31+00:00","breadcrumb":{"@id":"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/faus-moliner.com\/en\/liberalisation-of-discounts-offered-by-pharmaceutical-companies-to-pharmacies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/faus-moliner.com\/en\/"},{"@type":"ListItem","position":2,"name":"Liberalisation of discounts offered by pharmaceutical companies to pharmacies"}]},{"@type":"WebSite","@id":"https:\/\/faus-moliner.com\/en\/#website","url":"https:\/\/faus-moliner.com\/en\/","name":"faus-moliner.com","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/faus-moliner.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/faus-moliner.com\/en\/#organization","name":"Faus Moliner","url":"https:\/\/faus-moliner.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","width":400,"height":283,"caption":"Faus Moliner"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/2372042\/admin\/"]},{"@type":"Person","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260","name":"Jordi Faus","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5","url":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","caption":"Jordi Faus"},"description":"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.","sameAs":["https:\/\/faus-moliner.com\/"],"url":"https:\/\/faus-moliner.com\/en\/author\/jordi-faus\/"}]}},"_links":{"self":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/7285","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/comments?post=7285"}],"version-history":[{"count":0,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/7285\/revisions"}],"wp:attachment":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/media?parent=7285"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/categories?post=7285"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/tags?post=7285"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/coauthors?post=7285"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}